Fig. 3

Levels of (A) TAC and (B) hepatic MDA, (C) renal MDA. Data are presented as mean ± SD. One-way ANOVA (n = 6) followed by Tukey’s post-hoc test was utilized to examine significant differences, where ###; p < 0.001, compared to the control group. **; p < 0.01, ***; p < 0.001 compared to the GET group. TAC total antioxidant capacity, MDA malondialdehyde.